Skip to main content
. 2022 Feb 7;11:16. doi: 10.1186/s40249-022-00942-8

Table 3.

Hazard ratio in univariate analysis and multivariate analysis

Univariate analysis Multivariate analysis
Hazard ratio 95% CI P Hazard ratio 95% CI P
Age 1.02 1.01–1.04 0.015 1.04 1.02–1.06 0.001
Comorbidity 2.01 1.24–3.23 0.005 2.05 1.21–3.49 0.008
DNTM 1.81 1.12–2.90 0.015 2.08 1.17–3.68 0.012
HIV viral load 1.25 1.07–1.46 0.006 1.32 1.12–1.55 0.001
Linezolid 3.64 1.85–7.15 0.001 4.71 2.25–9.83 0.001
Sex 1.59 0.50–5.04 0.435 0.697
Smoking 0.86 0.31–2.35 0.764 0.411
Alcoholism 1.30 0.32–5.29 0.719 0.592
Opportunistic infection 0.98 0.60–1.61 0.946 0.411
CD4+ T cell count 1.00 1.00–1.00a 0.243 0.795
ART before NTM treatment 0.53 0.32–0.89 0.015 0.221
Time to culture positivity 0.98 0.96–1.01 0.125 0.232

Sex, age, smoking, alcoholism, comorbidity, opportunistic infection, CD4+ T cell count, HIV viral load, ART before NTM treatment, linezolid, DNTM and time to culture positivity were added to the model using stepwise procedures

–: blank (In the multivariate analysis, SPSS 25.0 did not show 95% CI and hazard ratio for variables that were not statistically significant); a: 95% CI for hazard ratio of CD4+ T cell count: 0.996–1.001

HIV human immunodeficiency virus, NTM nontuberculous mycobacteria, DNTM disseminated nontuberculous mycobacteria, ART antiretroviral therapy